Scisparc Stock Today
| SPRC Stock | USD 7.54 0.50 6.22% |
PerformanceOK
| Odds Of DistressLow
|
Scisparc is trading at 7.54 as of the 19th of July 2025, a 6.22 percent decrease since the beginning of the trading day. The stock's open price was 8.04. Scisparc has about a 21 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 20th of April 2025 and ending today, the 19th of July 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 30th of August 2021 | Category Healthcare | Classification Health Care |
SciSparc Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel. Scisparc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 534.6 K outstanding shares of which 89.41 K shares are at this time shorted by private and institutional investors with about 0.73 trading days to cover. More on Scisparc
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Scisparc Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| President Director | Itschak Shrem | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Stock Exchange Of, NASDAQ Composite, SET100 Index, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsScisparc can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Scisparc's financial leverage. It provides some insight into what part of Scisparc's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Scisparc (SPRC) is traded on NASDAQ Exchange in USA. It is located in Tower A, Tel Aviv, Israel, 6971916 and employs 2 people. Scisparc is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.03 M. Scisparc conducts business under Biotechnology sector and is part of Health Care industry. The entity has 534.6 K outstanding shares of which 89.41 K shares are at this time shorted by private and institutional investors with about 0.73 trading days to cover.
Scisparc currently holds about 6.88 M in cash with (5.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.15.
Check Scisparc Probability Of Bankruptcy
Ownership AllocationAbout 98.9 % of Scisparc outstanding shares are held by general public with 1.1 % by institutional holders.
Check Scisparc Ownership Details
Scisparc Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Two Sigma Securities, Llc | 2025-03-31 | 67.4 K | |
| Sbi Securities Co Ltd | 2025-03-31 | 285 | |
| Bank Of America Corp | 2025-03-31 | 42.0 | |
| Rhumbline Advisers | 2025-03-31 | 16.0 | |
| Morgan Stanley - Brokerage Accounts | 2025-03-31 | 5.0 | |
| Susquehanna International Group, Llp | 2025-03-31 | 0.0 | |
| Jpmorgan Chase & Co | 2025-03-31 | 0.0 | |
| Virtu Financial Llc | 2024-12-31 | 0.0 | |
| Ubs Group Ag | 2025-03-31 | 0.0 |
Scisparc Historical Income Statement
Scisparc Stock Against Markets
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Scisparc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Scisparc Stock refer to our How to Trade Scisparc Stock guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Scisparc. If investors know Scisparc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Scisparc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (22.66) | Revenue Per Share | Quarterly Revenue Growth (0.49) | Return On Assets | Return On Equity |
The market value of Scisparc is measured differently than its book value, which is the value of Scisparc that is recorded on the company's balance sheet. Investors also form their own opinion of Scisparc's value that differs from its market value or its book value, called intrinsic value, which is Scisparc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Scisparc's market value can be influenced by many factors that don't directly affect Scisparc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Scisparc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Scisparc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Scisparc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.